Wine and health

South African Journal of Science

Volumn 97, Issue 7-8, 2001, Pages 279-282

  Armstrong, G O ^a   Lambrechts, M G ^a   Mansvelt, E P G ^a   Van Velden, D P ^a   Pretorius, I S ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH AND SAFETY;

EID: 0034805558     PISSN: 00382353     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Red wine, white wine and diet, intervention study. Effect on cardiovascular risk factors
2. Review of the biology of quercetin and related bioflavonoids
3. Health issues
4. Wine, alcohol, platelets, and the French paradox for coronary heart disease
5. Health benefits of wine and grape juice
6. Beyond cholesterol. Modification of low-density lipoprotein that increases its atherogenicity
7. Antioxidants and atherosclerosis: A current assessment
8. Wine and vegetable oils - The French paradox re-visited
9. Oxidatively modified low-density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis
10. Low-density lipoprotein-induced cytotoxity and its inhibition by HDL in human vascularsmooth muscle and endothelial cells in culture
11. Salicylic acid in wine as a therapeutic agent in cardiovascular disease
12. Auxins
13. Nature, distribution and function of plant flavonoids
14. Flavonols in wine and tea and prevention of coronary heart disease
15. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and ecosanoid synthesis: Implications for protection against coronary heart disease
16. Wine as a biological fluid: History, production, and role in disease prevention
17. Flavonoids in food and natural antioxidants in wine
18. Polyphenolic flavonols as scavengers of aqueous phase radicals and as chain breaking antioxidants
19. The effect of adding supplementary quantities of seeds during fermentation on the phenolic composition of wines
20. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine
21. Principle phenolic phyto-chemicals in selected California wines and their antioxidant activity in inhibiting oxidation of human low-density lipoproteins
22. Quercetin and p-coumaric acid concentrations in commercial wines
23. Relative bioavailability of the antioxidant quercetin from various foods in man
24. Extensive binding of the bioflavonoid quercetin to human plasma proteins
25. Interest of polyphenols in preventive nutrition
26. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties
27. Bioavailability of flavonoids from various tea
28. Phytoalexin synthesis: The biochemical analysis of the induction process
29. Induction of stilbene synthase by Botrytis cinerea in cultured grapevine cells
30. Production of the phytoalexin resveratrol by grapes as a response to Botrytis under natural conditions
31. A global survey of trans-resveratrol concentrations in commercial wines
32. Resveratrol and piceid levels in wine production and in finished wine
33. Production of the phytoalexin resveratrol by grapes as a response to Botrytis attack under natural conditions
34. Identification and assay of trihydroystilbenes in wine and their biological properties
35. The occurrence of piceid, a stilbene glucoside, in grape berries
36. Occurrence of a resveratrol β-D-gucoside in wine: Preliminary studies
37. Direct injection gas chromatographic mass spectromectric assay for trans-resveratrol
38. Concentration of the phytoalexin resveratrol in wine
39. Benefits and risks of oestrogen replacement therapy
40. Decreased mortality in users of oestrogen replacement therapy
41. Decreased risk of stroke among postmenopausal hormone users: Results from a national cohort
42. Quality of life after the menopause: Influence of hormone replacement therapy
43. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'?
44. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the oestrogen receptor
45. Wine and health - It is more than alcohol
46. Role of salicylic acid in plants
47. Fibrin as a factor in atherogenesis
48. Detection of hydroxyl radicals by aromatic hydroxylation
49. Absorption kinetics of aspirin in man following oral administration of an aqueous solution
50. Pharmacology of platelet inhibition in humans: Implications of the salicylate-aspirin interaction
51. Alcohol and mortality: A ten year Kaiser-Permanente experience
52. Alcohol and other discriminants between cases of sudden death and myocardial infarction
53. Coronary heart disease mortality and alcohol consumption in Framingham
54. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction
55. Alcohol, health, and the heart: Implications for clinicians
56. Pattern of alcohol drinking and progression of atherosclerosis
57. Ethanol stimulates apolipoprotein A-I secretion by human hepatocytes: Implications for a mechanism for atherosclerosis prevention
58. Wine and grape juices as modulators of platelet aggregation in healthy human subjects
59. Mortality associated with moderate intakes of wine, beer or spirits
60. Effect of the consumption of alcohol, white wine, and red wine on platelet function and serum lipids
61. Differential effects of alcoholic beverages on experimental atherosclerosis in rabbits
62. Advances in Australian research into the cardio and cancer protective properties of wine
63. An investigation into the in vivo effect of regular red wine consumption on the aggregability of blood platelets